Home
AI Agent
Annotations
Files

Pricing and plans
Get the full experience
We save the real magic for signed-in users.

Home Stock Screener Document Search Charting Watchlists Recent Filings

Intellia Therapeutics, Inc.(NTLA US)

$9.70-0.858.06%Ext:$9.69-0.010.15%(Market Closed · 00:58:06 UTC)

Doc Search Profile Entity StructureFinancials Charting Short Interest Employees

Overview

Profile Entity Structure

Documents

Categorized Chronological By Owner

Financials & Metrics

Financials Charting Short Interest Employees

Home
AI Agent
Annotations
Files

Pricing and plans
Get the full experience
We save the real magic for signed-in users.

Home Stock Screener Document Search Charting Watchlists Recent Filings

Intellia Therapeutics, Inc.(NTLA US)

$9.70-0.858.06%Ext:$9.69-0.010.15%(Market Closed · 00:58:06 UTC)

Doc Search Profile Entity StructureFinancials Charting Short Interest Employees

Overview

Profile Entity Structure

Documents

Categorized Chronological By Owner

Financials & Metrics

Financials Charting Short Interest Employees

NTLA US

NTLA US

SEC Filings

SEC Filings

Financials(45)

10-QQ3ended 30 Sept 20265 Nov
10-QQ2ended 30 Jun 20266 Aug
10-QQ1ended 31 Mar 202611 May
10-KFY 2025ended 31 Dec 202526 Feb
10-QQ3ended 30 Sept 20256 Nov 2025
10-QQ2ended 30 Jun 20257 Aug 2025
10-QQ1ended 31 Mar 20258 May 2025
10-KFY 2024ended 31 Dec 202427 Feb 2025
10-QQ3ended 30 Sept 20247 Nov 2024
10-QQ2ended 30 Jun 20248 Aug 2024
10-QQ1ended 31 Mar 20249 May 2024
10-KFY 2023ended 31 Dec 202322 Feb 2024
10-QQ3ended 30 Sept 20239 Nov 2023
10-QQ2ended 30 Jun 20233 Aug 2023
10-QQ1ended 31 Mar 20234 May 2023

Events(140)

8-K/ARegulation FD Disclosure05:05PM
8-KResults of Operations and Financial Condition12 Nov
8-KResults of Operations and Financial Condition5 Nov
8-KRegulation FD Disclosure8 Sep
8-KIntellia Therapeutics SecuresNon-Dilutive4 Sep
8-KResults of Operations and Financial Condition6 Aug
8-KRegulation FD Disclosure15 Jun
8-KSubmission of Matters to a Vote of Security Holders10 Jun
8-KResults of Operations and Financial Condition11 May
8-KEntry into a Material Definitive Agreement30 Apr
8-K*** CONFIDENTIAL ***27 Apr
8-KAmendments to Articles of Incorporation or Bylaws; Change in Fiscal Year10 Apr
8-KAMENDMENT NO. 2 TO THE OPEN MARKET SALE AGREEMENTSM2 Mar
8-KResults of Operations and Financial Condition26 Feb
8-KIntellia Therapeutics Announces FDA Lift of Clinical Hold on27 Jan

Insider Ownership(353)

Form 4LEONARD JOHN M3 Nov
Form 4Marantz Jing L.28 Oct
Form 3Marantz Jing L.28 Oct
Form 4Dube Michael P6 Oct
Form 4LEONARD JOHN M24 Aug
Form 4Dulac Edward J III24 Jul
Form 4Dube Michael P6 Jul
Form 4Dulac Edward J III6 Jul
Form 4Verwiel Frank10 Jun
Form 4Keresty Georgia10 Jun
Form 4GOODMAN JESSE10 Jun
Form 4Goff Brian10 Jun
Form 4Cohen Fred E10 Jun
Form 4CHASE WILLIAM J10 Jun
Form 4Bhanji Muna10 Jun

Beneficial Ownership(76)

SC 13GIntellia Therapeutics, Inc.10 Nov
SC 13GIntellia Therapeutics, Inc.7 Aug
SC 13GIntellia Therapeutics, Inc.30 Apr
SC 13GIntellia Therapeutics, Inc.29 Apr
SC 13G/AIntellia Therapeutics, Inc.27 Mar
SC 13G/AIntellia Therapeutics, Inc.12 Feb
SC 13G/AIntellia Therapeutics, Inc.11 Feb
SC 13GIntellia Therapeutics, Inc.9 Feb
SC 13G/AIntellia Therapeutics, Inc.3 Feb
SC 13G/AIntellia Therapeutics, Inc.30 Jan
SC 13GIntellia Therapeutics, Inc.12 Nov 2025
SC 13GIntellia Therapeutics, Inc.12 Nov 2025
SC 13G/AIntellia Therapeutics, Inc.4 Nov 2025
SC 13GIntellia Therapeutics, Inc.13 May 2025
SC 13G/AIntellia Therapeutics, Inc.17 Apr 2025

Other Ownership(10)

Form 144LEONARD JOHN M2 Nov
Form 144Clark Eliana5 Oct
Form 144LEONARD JOHN M20 Aug
Form 144Dulac Edward J III2 Jul
Form 144LEONARD JOHN M11 Dec 2025
Form 144Sepp-Lorenzino Laura8 Jan 2024
Form 144Crowley John F7 Dec 2023
Form 144Bhanji Muna31 Jul 2023
Form 144Bhanji Muna6 Jul 2023
Form 144Clark Eliana20 Jun 2023

Proxies(24)

ARSAnnual report to security holders30 Apr
DEFA14ADefinitive additional materials30 Apr
DEF 14ADefinitive proxy statement30 Apr
ARSAnnual report to security holders30 Apr 2025
DEFA14ADefinitive additional materials30 Apr 2025
DEF 14ADefinitive proxy statement30 Apr 2025
ARSAnnual report to security holders29 Apr 2024
DEF 14ADefinitive proxy statement29 Apr 2024
DEFA14ADefinitive additional materials29 Apr 2024
PRE 14APreliminary proxy statement16 Apr 2024
DEFA14ADefinitive additional materials5 Jun 2023
DEFA14ADefinitive additional materials1 May 2023
DEF 14ADefinitive proxy statement1 May 2023
ARSAnnual report to security holders18 Apr 2023
DEFA14ADefinitive additional materials2 May 2022

Registrations(48)

424B5Prospectus filing (Rule 424(b)(5))29 Apr
424B5Prospectus filing (Rule 424(b)(5))27 Apr
424B5Prospectus filing (Rule 424(b)(5))2 Mar
S-8Registration statement (employee benefit plan)26 Feb
S-8Registration statement (employee benefit plan)11 Jun 2025
S-8Registration statement (employee benefit plan)28 Feb 2025
S-8Registration statement (employee benefit plan)18 Jul 2024
424B5Prospectus filing (Rule 424(b)(5))26 Feb 2024
424B5Prospectus filing (Rule 424(b)(5))23 Feb 2024
S-8Registration statement (employee benefit plan)22 Feb 2024
S-3ASRAutomatic shelf registration statement (S-3)24 Nov 2023
424B5Prospectus filing (Rule 424(b)(5))4 Mar 2022
S-8Registration statement (employee benefit plan)24 Feb 2022
424B5Prospectus filing (Rule 424(b)(5))1 Jul 2021
424B5Prospectus filing (Rule 424(b)(5))28 Jun 2021

Filing Review Correspondence(10)

CORRESPFiling review correspondence10 Sep 2019
CORRESPFiling review correspondence30 Aug 2019
CORRESPFiling review correspondence4 Jun 2019
CORRESPFiling review correspondence15 Jun 2017
CORRESPFiling review correspondence3 May 2016
CORRESPFiling review correspondence3 May 2016
CORRESPFiling review correspondence27 Apr 2016
CORRESPFiling review correspondence27 Apr 2016
CORRESPFiling review correspondence22 Apr 2016
CORRESPFiling review correspondence11 Apr 2016

SEC Orders And Notices(10)

CT ORDERConfidential treatment order1 Sep 2020
EFFECTNotice of effectiveness12 Sep 2019
EFFECTNotice of effectiveness6 Jun 2019
CT ORDERConfidential treatment order9 May 2019
CT ORDERConfidential treatment order11 Mar 2019
EFFECTNotice of effectiveness16 Jun 2017
CT ORDERConfidential treatment order7 Feb 2017
CT ORDERConfidential treatment order22 Dec 2016
CT ORDERConfidential treatment order6 May 2016
EFFECTNotice of effectiveness5 May 2016

Exempt Offerings(1)

D06b3 Sep 2015

Other(1)

CERTNASAUTO-GENERATED PAPER DOCUMENT5 May 2016

Financials(45)

10-QQ3ended 30 Sept 20265 Nov
10-QQ2ended 30 Jun 20266 Aug
10-QQ1ended 31 Mar 202611 May
10-KFY 2025ended 31 Dec 202526 Feb
10-QQ3ended 30 Sept 20256 Nov 2025
10-QQ2ended 30 Jun 20257 Aug 2025
10-QQ1ended 31 Mar 20258 May 2025
10-KFY 2024ended 31 Dec 202427 Feb 2025
10-QQ3ended 30 Sept 20247 Nov 2024
10-QQ2ended 30 Jun 20248 Aug 2024
10-QQ1ended 31 Mar 20249 May 2024
10-KFY 2023ended 31 Dec 202322 Feb 2024
10-QQ3ended 30 Sept 20239 Nov 2023
10-QQ2ended 30 Jun 20233 Aug 2023
10-QQ1ended 31 Mar 20234 May 2023

Events(140)

8-K/ARegulation FD Disclosure05:05PM
8-KResults of Operations and Financial Condition12 Nov
8-KResults of Operations and Financial Condition5 Nov
8-KRegulation FD Disclosure8 Sep
8-KIntellia Therapeutics SecuresNon-Dilutive4 Sep
8-KResults of Operations and Financial Condition6 Aug
8-KRegulation FD Disclosure15 Jun
8-KSubmission of Matters to a Vote of Security Holders10 Jun
8-KResults of Operations and Financial Condition11 May
8-KEntry into a Material Definitive Agreement30 Apr
8-K*** CONFIDENTIAL ***27 Apr
8-KAmendments to Articles of Incorporation or Bylaws; Change in Fiscal Year10 Apr
8-KAMENDMENT NO. 2 TO THE OPEN MARKET SALE AGREEMENTSM2 Mar
8-KResults of Operations and Financial Condition26 Feb
8-KIntellia Therapeutics Announces FDA Lift of Clinical Hold on27 Jan

Insider Ownership(353)

Form 4LEONARD JOHN M3 Nov
Form 4Marantz Jing L.28 Oct
Form 3Marantz Jing L.28 Oct
Form 4Dube Michael P6 Oct
Form 4LEONARD JOHN M24 Aug
Form 4Dulac Edward J III24 Jul
Form 4Dube Michael P6 Jul
Form 4Dulac Edward J III6 Jul
Form 4Verwiel Frank10 Jun
Form 4Keresty Georgia10 Jun
Form 4GOODMAN JESSE10 Jun
Form 4Goff Brian10 Jun
Form 4Cohen Fred E10 Jun
Form 4CHASE WILLIAM J10 Jun
Form 4Bhanji Muna10 Jun

Beneficial Ownership(76)

SC 13GIntellia Therapeutics, Inc.10 Nov
SC 13GIntellia Therapeutics, Inc.7 Aug
SC 13GIntellia Therapeutics, Inc.30 Apr
SC 13GIntellia Therapeutics, Inc.29 Apr
SC 13G/AIntellia Therapeutics, Inc.27 Mar
SC 13G/AIntellia Therapeutics, Inc.12 Feb
SC 13G/AIntellia Therapeutics, Inc.11 Feb
SC 13GIntellia Therapeutics, Inc.9 Feb
SC 13G/AIntellia Therapeutics, Inc.3 Feb
SC 13G/AIntellia Therapeutics, Inc.30 Jan
SC 13GIntellia Therapeutics, Inc.12 Nov 2025
SC 13GIntellia Therapeutics, Inc.12 Nov 2025
SC 13G/AIntellia Therapeutics, Inc.4 Nov 2025
SC 13GIntellia Therapeutics, Inc.13 May 2025
SC 13G/AIntellia Therapeutics, Inc.17 Apr 2025

Other Ownership(10)

Form 144LEONARD JOHN M2 Nov
Form 144Clark Eliana5 Oct
Form 144LEONARD JOHN M20 Aug
Form 144Dulac Edward J III2 Jul
Form 144LEONARD JOHN M11 Dec 2025
Form 144Sepp-Lorenzino Laura8 Jan 2024
Form 144Crowley John F7 Dec 2023
Form 144Bhanji Muna31 Jul 2023
Form 144Bhanji Muna6 Jul 2023
Form 144Clark Eliana20 Jun 2023

Proxies(24)

ARSAnnual report to security holders30 Apr
DEFA14ADefinitive additional materials30 Apr
DEF 14ADefinitive proxy statement30 Apr
ARSAnnual report to security holders30 Apr 2025
DEFA14ADefinitive additional materials30 Apr 2025
DEF 14ADefinitive proxy statement30 Apr 2025
ARSAnnual report to security holders29 Apr 2024
DEF 14ADefinitive proxy statement29 Apr 2024
DEFA14ADefinitive additional materials29 Apr 2024
PRE 14APreliminary proxy statement16 Apr 2024
DEFA14ADefinitive additional materials5 Jun 2023
DEFA14ADefinitive additional materials1 May 2023
DEF 14ADefinitive proxy statement1 May 2023
ARSAnnual report to security holders18 Apr 2023
DEFA14ADefinitive additional materials2 May 2022

Registrations(48)

424B5Prospectus filing (Rule 424(b)(5))29 Apr
424B5Prospectus filing (Rule 424(b)(5))27 Apr
424B5Prospectus filing (Rule 424(b)(5))2 Mar
S-8Registration statement (employee benefit plan)26 Feb
S-8Registration statement (employee benefit plan)11 Jun 2025
S-8Registration statement (employee benefit plan)28 Feb 2025
S-8Registration statement (employee benefit plan)18 Jul 2024
424B5Prospectus filing (Rule 424(b)(5))26 Feb 2024
424B5Prospectus filing (Rule 424(b)(5))23 Feb 2024
S-8Registration statement (employee benefit plan)22 Feb 2024
S-3ASRAutomatic shelf registration statement (S-3)24 Nov 2023
424B5Prospectus filing (Rule 424(b)(5))4 Mar 2022
S-8Registration statement (employee benefit plan)24 Feb 2022
424B5Prospectus filing (Rule 424(b)(5))1 Jul 2021
424B5Prospectus filing (Rule 424(b)(5))28 Jun 2021

Filing Review Correspondence(10)

CORRESPFiling review correspondence10 Sep 2019
CORRESPFiling review correspondence30 Aug 2019
CORRESPFiling review correspondence4 Jun 2019
CORRESPFiling review correspondence15 Jun 2017
CORRESPFiling review correspondence3 May 2016
CORRESPFiling review correspondence3 May 2016
CORRESPFiling review correspondence27 Apr 2016
CORRESPFiling review correspondence27 Apr 2016
CORRESPFiling review correspondence22 Apr 2016
CORRESPFiling review correspondence11 Apr 2016

SEC Orders And Notices(10)

CT ORDERConfidential treatment order1 Sep 2020
EFFECTNotice of effectiveness12 Sep 2019
EFFECTNotice of effectiveness6 Jun 2019
CT ORDERConfidential treatment order9 May 2019
CT ORDERConfidential treatment order11 Mar 2019
EFFECTNotice of effectiveness16 Jun 2017
CT ORDERConfidential treatment order7 Feb 2017
CT ORDERConfidential treatment order22 Dec 2016
CT ORDERConfidential treatment order6 May 2016
EFFECTNotice of effectiveness5 May 2016

Exempt Offerings(1)

D06b3 Sep 2015

Other(1)

CERTNASAUTO-GENERATED PAPER DOCUMENT5 May 2016